Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / Ordinary Shares, par value NIS 0.10 per share
-
Shares outstanding
-
1,147,663,152
-
Total 13F shares
-
593,337,830
-
Share change
-
-45,920,192
-
Total reported value
-
$4,080,614,277
-
Put/Call ratio
-
235%
-
Price per share
-
$6.88
-
Number of holders
-
381
-
Value change
-
-$370,869,093
-
Number of buys
-
153
-
Number of sells
-
205
Institutional Holders of TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.10 per share (TEVA) as of Q3 2019
As of 30 Sep 2019 TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.10 per share (TEVA) had 381 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 593,337,830 shares of stock of the company.
Largest 10 holders included Capital Research Global Investors, WELLINGTON MANAGEMENT GROUP LLP, Berkshire Hathaway Inc, FRANKLIN RESOURCES INC, BlackRock Inc., Capital World Investors, ABRAMS CAPITAL MANAGEMENT, L.P., STATE STREET CORP, CREDIT SUISSE AG/, and COMMERZBANK AKTIENGESELLSCHAFT /FI.
This table shows 381 institutional shareholders of the security as of 30 Sep 2019.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.